(Q33739135)

29 July 2017

1 reference

title

Fibrinogen and women's health (English)

1 reference

29 July 2017

Vorster HH

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

95

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

137-154

1 reference

The role of fibrinogen as a cardiovascular risk factor

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Atherogenesis and fibrinogen: historical perspective and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen: an important risk factor for atherothrombotic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen, a vascular risk factor: a simple marker or a real cause of vascular lesion?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen, viscosity and ischaemic heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The cost of being a woman.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Sense and sensitivity: developing a gender issues perspective in medical education

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Gender differences in health and health actions among community-dwelling elders.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Gender, social mobility and psychiatric diagnoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The primary prevention of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Cardiovascular disease in women: gender-specific aspects of hypertension and the consequences of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Association of genetic variation at the beta-fibrinogen gene locus and plasma fibrinogen levels; interaction between allele frequency of the G/A-455 polymorphism, age and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Studies on fibrin network structure in human plasma. Part One: Methods for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Effects of various fatty acids alone or combined with vitamin E on cell growth and fibrinogen concentration in the medium of HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Plasma fibrinogen and its correlates in Japanese and US population samples

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Plasma fibrinogen of black South Africans: the BRISK study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Passive smoking and plasma fibrinogen concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Plasma fibrinogen concentration in a Chinese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Diet and haemostatic processes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Diet and haemostasis: time for nutrition science to get more involved

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Seasonal variations in fibrinogen concentrations among elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Intra-individual variability of fibrinogen levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen levels and exercise. Is there a relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G- 453 -A Polymorphism of the β-Fibrinogen Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Coagulation and fibrinolysis in smoking and nonsmoking pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Hemostatic abnormalities may predict chronic hypertension after preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Antithrombin III and procoagulant activity: sex differences and effects of the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Plasma fibrinogen: its relationship with oral contraception, the menopause, and hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Oral contraceptives, fibrinogen and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

First-time use of newer oral contraceptives and the risk of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Epidemiology of oral contraceptives and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Risks and mechanisms of cardiovascular events in users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

An epidemiological study of the haemostatic and other effects of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Hormone replacement therapy and previous use of oral contraceptives among Swedish women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Compliance with hormone replacement therapy in Chinese women in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Postmenopausal hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen and plasminogen modifications during oral estradiol replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

The effects of hormone replacement therapy on coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen levels in women having coronary angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Fibrinogen: its role in the hemostatic regulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Coronary heart disease. Women's hearts are hard to break

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Hemostatic factors according to menopausal status and use of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

Influence of fibrinogen on cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900033-X

7 January 2021

10.1016/S0049-3848(99)00033-X

Identifiers

DOI

1 reference

release_m5v2o2tsm5eb3dstpwrnjacpyy

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m5v2o2tsm5eb3dstpwrnjacpyy

24 November 2022

mapped directly with Wikidata item

1 reference